TLR4 and neoplasm: LPS, a component of the outer membrane of Gram-negative bacteria, is an agonist of the TLR4 and can modify gene expression in various cell types; it has also been identified as a potential anti-tumor agent for glioblastoma treatment [8,10,11,13,37,48].